References
- Compalati E, Canonica GW. Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. Curr Med Res Opin 2013;29:1539-51
- Fantin S, Maspero J, Bisbal C, et al. International Rupatadine Study Group. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis. Allergy 2008;63:924-31
- Guadaño EM, Serra-Batlles J, Meseguer J, et al. Rupatadine Study Group. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study. Allergy 2004;59:766-71
- Berger VW. Conservative handling of missing information. J Clin Epidemiol 2012;65:1237-8
- Berger VW, Bears JD. When can a clinical trial be called ‘randomized’? Vaccine 2003;21:468-72
- Berger VW. Do not use blocked randomization. Headache 2006;46:343
- Berger VW. What do non-randomized trials offer above and beyond randomized trials? Contemp Clin Trials 2013;35:168-9